Clinical Trials Browser

Phase 2 × Completed × Isotretinoin × Clear all

NCT03033303 2025-10-07

A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma

Phase 2 Completed

Neuroblastoma

NCT02169609 2024-04-22

Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma

Phase 2 Completed

Neuroblastoma, Neoplasm, Residual

NCT00062010 2023-07-07

Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer

Phase 2 Completed

37 enrolled 8 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00005847 2023-06-22

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms

NCT00112502 2021-10-18

Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

Phase 2 Completed

178 enrolled 23 charts

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00528437 2021-07-08

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Phase 2 Completed

46 enrolled 5 charts

Brain Neoplasms, Ependymoma, Glioma, Recurrence

NCT00002586 2020-05-15

13-Cis

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma, Drug-Related Side Effects and Adverse Reactions

NCT01334515 2019-10-21

Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma

Phase 2 Completed

52 enrolled 11 charts

Neuroblastoma

NCT01183416 2019-10-09

High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation

Phase 2 Completed

4 enrolled 7 charts

Neuroblastoma

NCT01183429 2019-08-13

3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma

Phase 2 Completed

39 enrolled 6 charts

Neuroblastoma

NCT00038376 2018-10-29

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

Phase 2 Completed

LymphoidOther hematologic neoplasm

Mycosis Fungoides, Lymphoma, T-Cell, Hematologic Neoplasms

NCT02278861 2014-10-30

ARISOAK

Phase 2 Completed

Keratosis, Actinic

NCT00004110 2013-10-31

Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma

Phase 2 Completed

Neuroblastoma

NCT00021359 2013-07-10

Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00025038 2013-04-11

Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myelomonocytic, Juvenile

NCT00040872 2013-03-07

Multiple Therapies in Treating Patients With Advanced Neuroblastoma

Phase 2 Completed

Neuroblastoma

NCT00089258 2013-01-17

Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment

Phase 2 Completed

Neuroblastoma

NCT00002506 2011-05-12

Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer

Phase 2 Completed

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Penile Neoplasms, Skin Neoplasms

NCT00135135 2008-06-03

Therapy for Children With Neuroblastoma

Phase 2 Completed

Neoplasms, Neuroblastoma